読み込み中
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
前日終値
$127.51
+$1.45 · +1.15%
時間外
$125.99
−$1.52 · -1.19%
10月9日 19:59 ET
日中の時刻はETです。市場データは遅延する場合があります。
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
日中レンジ
現在 $127.51
52週レンジ
現在 $127.51
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
58
適正価値
センチメント
58
まちまち
リスク
48
やや高いリスク
モメンタム
48
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
日中レンジ
現在 $127.51
52週レンジ
現在 $127.51
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2026年度 | 2025年度 | 2024年度 | 2023年度 | 2022年度 |
|---|---|---|---|---|---|
| 売上高 | 2.49億 USD | 2.41億 USD | 2.16億 USD | 2.19億 USD | 1.84億 USD |
| 売上原価 | 9086万 USD | 9010.8万 USD | 8293.7万 USD | 8538.7万 USD | 7524.5万 USD |
| 粗利益 | 1.58億 USD | 1.51億 USD | 1.33億 USD | 1.34億 USD | 1.09億 USD |
| 研究開発 | 2030.8万 USD | 1951.8万 USD | 1930万 USD | 2049万 USD | 1576.7万 USD |
| 販売・一般管理 | 1.19億 USD | 1.15億 USD | 1.11億 USD | 1.1億 USD | 8862.1万 USD |
| 営業費用 | 1.4億 USD | 1.35億 USD | 4.05億 USD | 1.3億 USD | 1.04億 USD |
| 支払利息 | 1069.2万 USD | 1185.9万 USD | 569.7万 USD | 477万 USD | 388.5万 USD |
| 減価償却費と償却費 | 2327.1万 USD | 2452.7万 USD | 3157.4万 USD | 3313.4万 USD | 2506.8万 USD |
| 営業利益 | 1851.1万 USD | 1633.6万 USD | −2.72億 USD | 332万 USD | 470.2万 USD |
| 純利益 | 671.2万 USD | −197.4万 USD | −2.54億 USD | 93万 USD | 187.1万 USD |
会社概要が更新されました 2026年10月10日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$110
下落余地（13.73%）分割調整後の1株当たりの年間現金分配金。
$0.64
2025年（通年）0.0% 以来 2021
2026年（一部）：$0.48
$0.64
2,021
$0.64
2,022
$0.64
2,023
$0.64
2,024
$0.64
2,025
$0.48
2,026*
* 利用可能な配当履歴のうち、暦年の一部のみを含みます。
| 種別 | 配当落ち日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
配当 | 2026年8月31日 | $0.16Quarterly | 2026年8月31日 | 2026年9月15日 |
配当 | 2026年5月29日 | $0.16Quarterly | 2026年5月29日 | 2026年6月15日 |
配当 | 2026年2月27日 | $0.16Quarterly | 2026年2月28日 | 2026年3月16日 |
配当 | 2025年11月28日 | $0.16Quarterly | 2025年11月28日 | 2025年12月15日 |
配当 | 2025年8月29日 | $0.16Quarterly | 2025年8月29日 | 2025年9月15日 |
配当 | 2025年5月30日 | $0.16Quarterly | 2025年5月30日 | 2025年6月16日 |
配当落ち 2026年8月31日
$0.16
Quarterly
2026年8月31日基準 · 支払日 2026年9月15日
配当落ち 2026年5月29日
$0.16
Quarterly
2026年5月29日基準 · 支払日 2026年6月15日
配当落ち 2026年2月27日
$0.16
Quarterly
2026年2月28日基準 · 支払日 2026年3月16日
配当落ち 2025年11月28日
$0.16
Quarterly
2025年11月28日基準 · 支払日 2025年12月15日
配当落ち 2025年8月29日
$0.16
Quarterly
2025年8月29日基準 · 支払日 2025年9月15日
配当落ち 2025年5月30日
$0.16
Quarterly
2025年5月30日基準 · 支払日 2025年6月16日
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI2154.75万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM1817.18万0.02%782.66億 USD0.19%$278.94+0.49%
Keeley Dividend ETFKDVD1758.8万2.20%800万 USD0.90%$27.7170.00%
Vanguard Extended Market ETFVXF819.8万0.01%954億 USD0.05%$235+0.80%
Fidelity Enhanced Small Cap ETFFESM683.03万0.10%64.1億 USD0.28%$45.46+0.46%
iShares Russell 2000 Growth ETFIWO630.96万0.05%139.72億 USD0.24%$356.78+0.94%
Dimensional - US Targeted Value ETFDFAT535.89万0.02%301.22億 USD0.33%$67.27-0.43%
Dimensional - US Small Cap ETFDFAS462.1万0.01%338.69億 USD0.31%$78.35+0.32%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMKeeley Dividend ETFKDVDVanguard Extended Market ETFVXFFidelity Enhanced Small Cap ETFFESMiShares Russell 2000 Growth ETFIWODimensional - US Targeted Value ETFDFATDimensional - US Small Cap ETFDFASAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
